The Affordable Care Act incentivizes prevention, which is the process of identifying and remedying a disease before it occurs. With well-known diseases such as coronary artery disease, which costs the United States about $43 billion per year, there are well-established…
Defining Personalized Health Care
As a result of the announcement of the Precision Healthcare Initiative by President Obama at the end of January, innovative structures for improving healthcare are in the spotlight. In the media, there has been a lot of conversation about healthcare…
Precise But (Not Yet) Personal
Despite great advance in the field of personalized medicine and precision care therapies, there is still a dearth of progress in clinical models that use these emerging technologies to enhance preventive medicine. Precise But (Not Yet) Personal Ralph Snyderman President…
Obama to Request Research Funding for Treatments Tailored to Patients’ DNA
President Obama is seeking hundreds of millions of dollars to develop medical treatments tailored to the individual. Dr Snyderman offers his insight in the following NYTimes article regarding this precision medicine initiative. President Obama will seek hundreds of millions of…
Industry Voices: Inside Genomics–Q&A with Bina CEO Narges Bani Asadi and Dr. Ralph Snyderman
By Narges Bani Asadi Published on FierceBiotech (http://www.fiercebiotech.com) January 24, 2014 One of the elements lacking in the personalized medicine discussion today is the perspective of leading clinicians, informaticists and academics working in the field. To remedy the gap, I’ve…
Ten Years into Personalized Medicine: What We’ve Learned and What’s Next
Originally posted on Healthcommentary.org on January 17, 2014 Ten years ago, the sequencing of the entire human genome, along with the development of aggregate “omics” technologies began giving rise to a fundamentally new capability for the practice of medicine –…
Copyright © 2023 Duke Medicine